2,5-Deoxyfructosazine
CAS: 17460-13-8
Ref. 3D-MD16678
1mg | 325,00 € | ||
2mg | 452,00 € | ||
5mg | 678,00 € | ||
10mg | 1.054,00 € | ||
25mg | 1.823,00 € |
Produktinformation
- (1R,2S,3R)-1-[5-[(2S,3R)-2,3,4-Trihydroxybutyl]-2-pyrazinyl]-1,2,3,4-butanetetrol2-(D-arabino-tetrahydroxybutyl)-5-(D-erythro-2,3,4 -trihydroxybutyl)pyrazineNSC 270912
- Nsc 270912
- 1,2,3,4-Butanetetrol, 1-(5-(2,3,4-trihydroxybutyl)pyrazinyl)-, (1R-(1R*(2S*,3R*),2S*,3R*))-
- (1R,2S,3R)-1-{5-[(2S,3R)-2,3,4-trihydroxybutyl]pyrazin-2-yl}butane-1,2,3,4-tetrol
- 1-[5-(2,3,4-Trihydroxybutyl)Pyrazin-2-Yl]Butane-1,2,3,4-Tetrol
- Deoxyfructosazine
2,5-Deoxyfructosazine is a physiological agent that inhibits the growth of bacteria and fungi. 2,5-Deoxyfructosazine is active against Gram-positive and Gram-negative bacteria, as well as Candida albicans and other yeasts. This drug is effective in inhibiting water vapor loss in the lungs and has been shown to be an effective antimicrobial agent for the treatment of acute lung infections. 2,5-Deoxyfructosazine has been shown to reduce the development of antibiotic resistance in bacteria by preventing cell wall synthesis. The mechanism of action is thought to involve a matrix effect with cationic compounds, which are deposited on the surface of bacterial cells and destroy them by osmotic lysis. 2,5-Deoxyfructosazine also has antidiabetic effects due to its ability to inhibit glucose uptake into cells by binding to glucose transporters on the cell membrane. A reaction mechanism for this process involves hydrogen
Chemische Eigenschaften
Technische Anfrage zu: 3D-MD16678 2,5-Deoxyfructosazine
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.